What are the safest options to manage tobacco cravings during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Managing Tobacco Cravings During Pregnancy: Safe Options

Pregnancy-tailored behavioral counseling is the safest and most effective first-line approach for managing tobacco cravings during pregnancy, while pharmacotherapy should be considered only when counseling fails and after careful shared decision-making about risks and benefits.

First-Line Approach: Behavioral Interventions

Behavioral interventions are strongly recommended as the primary approach for pregnant women with tobacco cravings due to their proven effectiveness and safety:

  • Counseling interventions: Pregnancy-tailored counseling sessions have been shown to increase abstinence rates compared to brief, generic interventions 1. These should include:

    • Clear messages about effects of smoking on maternal and fetal health
    • Strong advice to quit as soon as possible
    • Self-help materials specifically designed for pregnant women
    • Problem-solving guidance to overcome barriers to quitting
  • Intensity matters: More intensive counseling shows better results, with quit rates plateauing after about 90 minutes of total counseling contact time 1

  • Support systems:

    • Telephone quit lines (particularly beneficial for those with mobility or transportation challenges) 2
    • Social support networks
    • Regular follow-up at prenatal visits

When Behavioral Interventions Are Insufficient

For pregnant women who cannot quit with behavioral interventions alone, pharmacotherapy options may be considered, though evidence is limited:

Nicotine Replacement Therapy (NRT)

  • Evidence is mixed: Few clinical trials have evaluated NRT in pregnant women. Although most studies showed a trend toward benefit, no statistically significant increase in cessation rates has been demonstrated 1

  • Safety considerations:

    • NRT is classified as FDA pregnancy category D (positive evidence of fetal risk) 1
    • Potential maternal adverse events include slightly increased diastolic blood pressure and skin reactions to patches 1
    • However, it has been suggested that NRT may be safer than continued smoking during pregnancy since cigarette smoke contains thousands of chemicals beyond nicotine, many of which are documented reproductive toxins 3
    • Intermittent-use formulations (gum, spray, inhaler) may be preferable to continuous-use formulations (patch) as they deliver less total nicotine to the fetus 3

Other Pharmacotherapy

  • Bupropion SR and varenicline: The USPSTF identified no studies on these medications for tobacco cessation during pregnancy 1. Both are pregnancy category C medications.

E-Cigarettes/Vaping Products

  • Not recommended: There is insufficient evidence regarding the safety and effectiveness of e-cigarettes for smoking cessation during pregnancy 1, 4
  • The USPSTF found inadequate evidence to conclude that e-cigarettes increase smoking cessation rates 1
  • E-cigarettes contain and emit numerous potentially toxic substances in addition to nicotine 1

Decision-Making Algorithm

  1. Start with comprehensive behavioral interventions:

    • Pregnancy-specific counseling
    • Telephone quit lines
    • Social support systems
    • Regular follow-up
  2. If behavioral interventions fail after thorough attempts:

    • Assess severity of tobacco dependence
    • Discuss risks of continued smoking versus potential risks of NRT
    • Consider NRT only after thorough shared decision-making
    • If using NRT, prefer intermittent-use formulations over continuous-use ones
  3. Avoid:

    • E-cigarettes/vaping products
    • Bupropion or varenicline (insufficient safety data)

Important Considerations

  • Timing matters: Quitting smoking early in pregnancy (before 15 weeks gestation) provides the greatest benefit to the fetus 5, but cessation at any point yields substantial health benefits for both mother and baby 1

  • Health risks of continued smoking: Smoking during pregnancy is associated with orofacial clefts, fetal growth restriction, placenta previa, abruptio placentae, preterm prelabor rupture of membranes, low birth weight, increased perinatal mortality, and ectopic pregnancy 5. Children born to women who smoke during pregnancy have increased risk of respiratory infections, asthma, infantile colic, bone fractures, and childhood obesity 5

  • Documentation: Available cessation-aid services and resources should be discussed and documented regularly at prenatal and postpartum follow-up visits 5

Pitfalls to Avoid

  • Assuming one approach fits all: The severity of tobacco dependence varies widely among pregnant women
  • Underestimating the power of behavioral interventions: Many providers jump to pharmacotherapy too quickly
  • Neglecting follow-up: Ongoing support throughout pregnancy is crucial for maintaining cessation
  • Recommending e-cigarettes: Despite their popularity, there is insufficient evidence for their safety and efficacy during pregnancy

Remember that approximately 54% of women who smoke before pregnancy quit smoking directly before or during pregnancy 5, indicating that pregnancy is a powerful motivator for smoking cessation that can be leveraged in counseling approaches.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Smoking Cessation in Older Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Tobacco use during pregnancy.

Addiction (Abingdon, England), 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.